Treatment of KPC-2 Enterobacter cloacae empyema with cefepime and levofloxacin

Anthony P. Cardile, Heather Briggs, S. Rodrigo Burguete, Monica Herrera, Brian L. Wickes, James H. Jorgensen

Research output: Contribution to journalArticle

7 Scopus citations


Carbapenem-resistant Enterobacteriaceae infections are becoming more common, are associated with high mortality rates, and are difficult to treat due to multiple mechanisms of resistance. We describe the successful treatment of Klebsiella pneumoniae carbapenemase-expressing Enterobacter cloacae empyema in a lung transplant recipient with cefepime and levofloxacin.

Original languageEnglish (US)
Pages (from-to)199-200
Number of pages2
JournalDiagnostic Microbiology and Infectious Disease
Issue number2
StatePublished - Feb 1 2014


  • Carbapenemase
  • Empyema
  • Enterobacter cloacae
  • KPC

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Treatment of KPC-2 Enterobacter cloacae empyema with cefepime and levofloxacin'. Together they form a unique fingerprint.

  • Cite this